Bristol Myers Squibb Stock Analysis

BMY Stock  USD 41.24  0.30  0.72%   
Bristol Myers Squibb is undervalued with Real Value of 49.6 and Target Price of 71.57. The main objective of Bristol Myers stock analysis is to determine its intrinsic value, which is an estimate of what Bristol Myers Squibb is worth, separate from its market price. There are two main types of Bristol Myers' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Bristol Myers' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Bristol Myers' stock to identify patterns and trends that may indicate its future price movements.
The Bristol Myers stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Bristol Myers is usually not traded on Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Bristol Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Bristol Myers' ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.

Bristol Stock Analysis Notes

About 79.0% of the company shares are held by institutions such as insurance companies. The book value of Bristol Myers was currently reported as 8.14. The company has Price/Earnings To Growth (PEG) ratio of 2.24. Bristol Myers Squibb recorded a loss per share of 3.1. The entity last dividend was issued on the 4th of April 2024. The firm had 1000000:95 split on the 7th of August 2001. Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 32200 people. For more info on Bristol Myers Squibb please contact Giovanni Caforio at 609 252 4621 or go to

Bristol Myers Quarterly Total Revenue

11.87 Billion

Bristol Myers Squibb Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bristol Myers' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bristol Myers Squibb or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bristol Myers Squibb generated a negative expected return over the last 90 days
Bristol Myers Squibb has a strong financial position based on the latest SEC filings
Over 79.0% of the company shares are held by institutions such as insurance companies
On 1st of May 2024 Bristol Myers paid $ 0.6 per share dividend to its current shareholders
Latest headline from Bonds Break Down And Send Everyone To Cash

Bristol Myers Squibb Upcoming and Recent Events

Earnings reports are used by Bristol Myers to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bristol Myers previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
2nd of February 2024
Upcoming Quarterly Report
25th of April 2024
Next Financial Report
31st of December 2023
Next Fiscal Quarter End
2nd of February 2024
Next Fiscal Year End
30th of September 2023
Last Quarter Report
31st of December 2022
Last Financial Announcement

Bristol Largest EPS Surprises

Earnings surprises can significantly impact Bristol Myers' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Bristol Myers Environmental, Social, and Governance (ESG) Scores

Bristol Myers' ESG score is a quantitative measure that evaluates Bristol Myers' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Bristol Myers' operations that may have significant financial implications and affect Bristol Myers' stock price as well as guide investors towards more socially responsible investments.

Bristol Myers Thematic Classifications

In addition to having Bristol Myers stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Compulsion Idea
Addiction driven consumer products and services

Bristol Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bristol Myers is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bristol Myers Squibb backward and forwards among themselves. Bristol Myers' institutional investor refers to the entity that pools money to purchase Bristol Myers' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Northern Trust Corp2023-12-31
24 M
Primecap Management Company2023-12-31
23.5 M
Bank Of America Corp2023-12-31
20.7 M
Legal & General Group Plc2023-12-31
19.8 M
Bank Of New York Mellon Corp2023-12-31
17 M
Dimensional Fund Advisors, Inc.2023-12-31
17 M
Dodge & Cox2023-12-31
16.2 M
Amvescap Plc.2023-12-31
15.6 M
Independent Franchise Partners Llp2023-12-31
14.1 M
Vanguard Group Inc2023-12-31
198.2 M
Blackrock Inc2023-12-31
168.1 M
Note, although Bristol Myers' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bristol Market Capitalization

The company currently falls under 'Large-Cap' category with a total capitalization of 83.6 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bristol Myers's market, we take the total number of its shares issued and multiply it by Bristol Myers's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Bristol Profitablity

Bristol Myers' profitability indicators refer to fundamental financial ratios that showcase Bristol Myers' ability to generate income relative to its revenue or operating costs. If, let's say, Bristol Myers is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bristol Myers' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bristol Myers' profitability requires more research than a typical breakdown of Bristol Myers' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (0.13) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 0.19 %, which entails that for every 100 dollars of revenue, it generated $0.19 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.15 
Return On Capital Employed 0.24  0.29 
Return On Assets 0.08  0.14 
Return On Equity 0.27  0.30 

Management Efficiency

Bristol Myers Squibb has Return on Asset of 0.0539 % which means that on every $100 spent on assets, it made $0.0539 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2533) %, meaning that it generated no profit with money invested by stockholders. Bristol Myers' management efficiency ratios could be used to measure how well Bristol Myers manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Bristol Myers' Return On Capital Employed is fairly stable compared to the past year. Return On Assets is likely to rise to 0.14 in 2024, whereas Return On Tangible Assets are likely to drop 0.15 in 2024. At this time, Bristol Myers' Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 66.6 B in 2024, whereas Other Assets are likely to drop slightly above 3.3 B in 2024.
Last ReportedProjected for Next Year
Book Value Per Share 14.22  14.94 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share(9.26)(8.80)
Enterprise Value Over EBITDA 7.10  12.22 
Price Book Value Ratio 3.61  6.92 
Enterprise Value Multiple 7.10  12.22 
Price Fair Value 3.61  6.92 
Enterprise Value107.1 B112.4 B
The analysis of Bristol Myers' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Bristol Myers' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Bristol Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
Forward Dividend Yield
Forward Dividend Rate

Technical Drivers

As of the 26th of May, Bristol Myers shows the Standard Deviation of 1.57, mean deviation of 1.01, and Risk Adjusted Performance of (0.11). Bristol Myers Squibb technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have collected data for thirteen technical drivers for Bristol Myers Squibb, which can be compared to its peers. Please confirm Bristol Myers Squibb coefficient of variation and value at risk to decide if Bristol Myers Squibb is priced correctly, providing market reflects its regular price of 41.24 per share. Given that Bristol Myers has information ratio of (0.22), we suggest you to validate Bristol Myers Squibb's prevailing market performance to make sure the company can sustain itself at a future point.

Bristol Myers Squibb Price Movement Analysis

Execute Study
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Bristol Myers middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Bristol Myers Squibb. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Bristol Myers Squibb Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bristol Myers insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bristol Myers' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bristol Myers insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bristol Myers Outstanding Bonds

Bristol Myers issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bristol Myers Squibb uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bristol bonds can be classified according to their maturity, which is the date when Bristol Myers Squibb has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Bristol Myers Predictive Daily Indicators

Bristol Myers intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bristol Myers stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bristol Myers Corporate Filings

9th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
3rd of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
25th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
22nd of April 2024
Other Reports
2nd of April 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
28th of March 2024
Other Reports
18th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
12th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities

Bristol Myers Forecast Models

Bristol Myers' time-series forecasting models are one of many Bristol Myers' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bristol Myers' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Bristol Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bristol Myers prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bristol shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Bristol Myers. By using and applying Bristol Stock analysis, traders can create a robust methodology for identifying Bristol entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.19  0.23 
Operating Profit Margin 0.38  0.25 
Net Profit Margin 0.18  0.18 
Gross Profit Margin 0.76  0.80 

Current Bristol Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bristol analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bristol analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
Bristol Myers Squibb current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bristol analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bristol stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bristol Myers Squibb, talking to its executives and customers, or listening to Bristol conference calls.
Bristol Analyst Advice Details

Bristol Stock Analysis Indicators

Bristol Myers Squibb stock analysis indicators help investors evaluate how Bristol Myers stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bristol Myers shares will generate the highest return on investment. By understating and applying Bristol Myers stock analysis, traders can identify Bristol Myers position entry and exit signals to maximize returns.
Begin Period Cash Flow9.3 B
Long Term Debt36.7 B
Common Stock Shares Outstanding2.1 B
Total Stockholder Equity29.4 B
Total Cashflows From Investing Activities-2.3 B
Tax Provision322 M
Quarterly Earnings Growth Y O Y-0.089
Property Plant And Equipment NetB
Cash And Short Term Investments12.3 B
Cash11.5 B
Accounts Payable3.3 B
Net Debt30 B
50 Day M A47.7558
Total Current Liabilities22.3 B
Other Operating Expenses36.8 B
Non Current Assets Total63.4 B
Forward Price Earnings6.93
Non Currrent Assets Other1.9 B
Stock Based Compensation518 M
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bristol Myers Squibb. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Bristol Stock analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
Dividend Share
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.